Hershey CEO Focuses on Cultural Relevance and GLP-1 Drug Impact

Hershey CEO Kirk Tanner has expressed concern that a brand's cultural relevance fading is a sign that one should be worried. Tanner stated that the company is actively working to ensure this never happens, focusing on keeping the brand current with a shifting culture.

Tanner also revealed that users of GLP-1 drugs, often focused on weight management, have surprisingly proven beneficial for the candy company. While users may consume products in smaller quantities, they do not want to give up their favorite treats. Hershey offers portion control as a solution, with over 30% of its product portfolio designed for smaller sizes.

Furthermore, Tanner described how artificial intelligence is being used to route sales forces in real time to retailers like Target and Walmart. This use of technology helps ensure the iconic brand finds new ways to remain relevant and energetic with consumers in today's market.

The company has also expanded its portfolio to include "permissible snacks" such as SkinnyPop popcorn and LesserEvil snacks. According to Tanner, these products meet consumers' growing demand for healthier yet enjoyable options, building a business around permissible snacking.